Literature DB >> 24764779

Interferon-free regimens and direct-acting antiviral agents.

Paul J Pockros1.   

Abstract

Year:  2013        PMID： 24764779      PMCID： PMC3992059     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

1.  Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.

Authors:  Mark S Sulkowski; Kenneth E Sherman; Douglas T Dieterich; Mohammad Bsharat; Lisa Mahnke; Jürgen K Rockstroh; Shahin Gharakhanian; Scott McCallister; Joshua Henshaw; Pierre-Marie Girard; Bambang Adiwijaya; Varun Garg; Raymond A Rubin; Nathalie Adda; Vincent Soriano
Journal:  Ann Intern Med       Date:  2013-07-16       Impact factor: 25.391

Review 2.  Direct-acting antiviral agents and the path to interferon independence.

Authors:  Warren N Schmidt; David R Nelson; Jean-Michel Pawlotsky; Kenneth E Sherman; David L Thomas; Raymond T Chung
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-18       Impact factor: 11.382

Review 3.  HCV RNA viral load assessments in the era of direct-acting antivirals.

Authors:  Bryan Cobb; Paul J Pockros; Regis A Vilchez; John M Vierling
Journal:  Am J Gastroenterol       Date:  2013-04       Impact factor: 10.864

Review 4.  What are the promising new therapies in the field of chronic hepatitis C after the first-generation direct-acting antivirals?

Authors:  Douglas Hunt; Paul Pockros
Journal:  Curr Gastroenterol Rep       Date:  2013-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.